Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

NorthX Biologics and Demeetra today announced a strategic collaboration combining a best-in-class high-titer GS (-/-) CHO cell line with full freedom to operate and no additional IP-related costs, ...

TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability. The platform has achieved ...

Viral vectors with Baboon endogenous virus (BaEV) envelope proteins have been demonstrated to markedly increase gene transfer efficiency to NK cells. Nevertheless, the cytotoxicity of the BaEV ...

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. Regarding the success of these strategies and the development ...

Cell Engineering Technology Will Address Unmet Therapeutic Needs by Reducing Cost and Increasing Availability of Gene Therapy SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CHO Plus, Inc. (www.CHO-Plus ...

An international team of researchers led by the University of California San Diego has developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are ...